| Trial ID: | L1540 |
| Source ID: | NCT01906840
|
| Associated Drug: |
Turmeric
|
| Title: |
Role of Turmeric on Oxidative Modulation in ESRD Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Failure
|
| Interventions: |
DRUG: Turmeric|DRUG: placebo
|
| Outcome Measures: |
Primary: effects of turmeric on oxidative stress markers, 8 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Shiraz University of Medical Sciences
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2011-04
|
| Completion Date: |
2012-08
|
| Results First Posted: |
|
| Last Update Posted: |
2013-07-24
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01906840
|
